Phase III interlaboratory study of FETAX, Part 2: interlaboratory validation of an exogenous metabolic activation system for frog embryo teratogenesis assay--Xenopus (FETAX).

Saved in:
Bibliographic Details
Title: Phase III interlaboratory study of FETAX, Part 2: interlaboratory validation of an exogenous metabolic activation system for frog embryo teratogenesis assay--Xenopus (FETAX).
Authors: Fort DJ; STOVER GROUP, Stillwater, OK, USA., Stover EL, Bantle JA, Rayburn JR, Hull MA, Finch RA, Burton DT, Turley SD, Dawson DA, Linder G, Buchwalter D, Dumont JN, Kumsher-King M, Gaudet-Hull AM
Source: Drug and chemical toxicology [Drug Chem Toxicol] 1998 Feb; Vol. 21 (1), pp. 1-14.
Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info: Publisher: Taylor & Francis Group Country of Publication: United States NLM ID: 7801723 Publication Model: Print Cited Medium: Print ISSN: 0148-0545 (Print) Linking ISSN: 01480545 NLM ISO Abbreviation: Drug Chem Toxicol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0148-0545
DOI:10.3109/01480549809017846